Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer
Santin AD, Bellone S, Siegel ER, Palmieri M, Thomas M, Cannon MJ, Kay HH, Roman JJ, Burnett A, Pecorelli S. Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer. American Journal Of Obstetrics And Gynecology 2005, 192: 813-818. PMID: 15746676, DOI: 10.1016/j.ajog.2004.10.605.Peer-Reviewed Original ResearchConceptsHER2/neu expressionEndometrial cancerNeu expressionProportional hazards modelWhite patientsBlack patientsPoor outcomeHigh HER2/neu expressionUterine serous papillary cancerCox proportional hazards modelHER2/neu overexpressionEndometrial cancer survivalMultivariate Cox regressionMajor prognostic indicatorHER2/neu oncogeneRacial differencesNovel treatment strategiesHER2/neuType II receptorStage IAAggressive variantMultivariable analysisUnivariable analysisCorpus uteriCox regression